LY3298176, a novel long-actingGIP/GLP-1 coagonist, shows enhanced activity on weight loss and energy utilization whilst maintaining its efficacy for glycaemic control
Emerging therapies: novel mechanistic targets arising from pathobiology In recent years, significant advancements have been achieved in the treatment of IBD, particularly with the introduction of biologic agents, which have substantially improved disease management
"Once we figured out I was insulin resistant, everything made sense and things started to come together." Sarah, Patient at Fertility Answers Metformin for PCOS (what it does & natural treatment options) Conclusion Metformin plays a key role in managing PCOS by addressing insulin resistance, a primary factor behind many of its symptoms
One study pitting semaglutide against tirzepatide saw the tirzepatide group lose 5.4% more body weight than the semaglutide group after 72 weeks.9 Liraglutide Of the three GLP-1 RAs in Henrys catalog, liraglutide may be the weakest
On the flip side, when the estrobolome is out of balance, it may contribute to certain inflammation-related health conditions, such as endometriosis and IBS